Immunic reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunic using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.21 | $-0.23 | 8.70 % |
Mar 2024 | 2024-05-08 | $-0.30 | $-0.26 | -15.4 % |
Dec 2023 | 2024-02-22 | $-0.48 | $-0.51 | 5.88 % |
Sep 2023 | 2023-11-14 | $-0.51 | $-0.55 | 7.27 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Immunic (IMUX) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.21, which beat the estimate of $-0.23.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.